View in EDS PDF Full Text

Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer.

Saved in:
Bibliographic Details
Title: Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer.
Authors: Kirby, A. M.1, A'hern, R. P.2, D'ambrosio, C.1, Tanay, M.1, Syrigos, K. N.1, Rogers, S. J.3, Box, C.3, Eccles, S. A.3, Nutting, C. M.1, Harrington, K. J.1,4
Source: British Journal of Cancer. 3/13/2006, Vol. 94 Issue 5, p631-636. 6p. 3 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6602999